Gilead had a "mildly disappointing" fourth quarter that featured two high-profile misses from HIV drugs. GILD stock hit a four-month low.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Gilead Reports ‘Mildly Disappointing’ Quarterly Results With An Unexpected High Point